Rep. Jefferson Shreve Purchases Shares of The Cigna Group (NYSE:CI)

Representative Jefferson Shreve (R-Indiana) recently bought shares of The Cigna Group NYSE: CI. In a filing disclosed on March 09th, the Representative disclosed that they had bought between $15,001 and $50,000 in The Cigna Group stock on February 24th. The trade occurred in the Representative's "CRT - STANDARD UNIT TRUST" account.

Representative Jefferson Shreve also recently made the following trade(s):

• Sold $15,001 - $50,000 in shares of AvalonBay Communities NYSE: AVB on 2/24/2025.
• Purchased $15,001 - $50,000 in shares of RTX NYSE: RTX on 2/24/2025.
• Purchased $15,001 - $50,000 in shares of Royal Gold NASDAQ: RGLD on 2/24/2025.
• Purchased $15,001 - $50,000 in shares of QUALCOMM NASDAQ: QCOM on 2/24/2025.
• Purchased $15,001 - $50,000 in shares of Pfizer NYSE: PFE on 2/24/2025.
• Sold $15,001 - $50,000 in shares of Norfolk Southern NYSE: NSC on 2/24/2025.
• Purchased $15,001 - $50,000 in shares of CoStar Group NASDAQ: CSGP on 2/24/2025.
• Purchased $50,001 - $100,000 in shares of AbbVie NYSE: ABBV on 2/24/2025.
• Purchased $15,001 - $50,000 in shares of Johnson & Johnson NYSE: JNJ on 2/24/2025.
• Purchased $15,001 - $50,000 in shares of Adobe NASDAQ: ADBE on 2/24/2025.

The Cigna Group Trading Down 2.9 %

Shares of The Cigna Group stock traded down $9.44 during trading hours on Tuesday, hitting $317.24. The company's stock had a trading volume of 1,955,263 shares, compared to its average volume of 1,870,027. The company has a market capitalization of $86.82 billion, a PE ratio of 25.92, a price-to-earnings-growth ratio of 0.98 and a beta of 0.53. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.66 and a quick ratio of 0.72. The stock has a 50 day moving average of $293.88 and a 200 day moving average of $317.40. The Cigna Group has a 12 month low of $262.03 and a 12 month high of $370.83.

Remove Ads

The Cigna Group (NYSE:CI - Get Free Report) last posted its earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same period in the prior year, the firm earned $6.79 EPS. Analysts predict that The Cigna Group will post 29.77 earnings per share for the current year.

The Cigna Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 20th. Investors of record on Wednesday, March 5th will be paid a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a yield of 1.90%. The ex-dividend date of this dividend is Wednesday, March 5th. This is an increase from The Cigna Group's previous quarterly dividend of $1.40. The Cigna Group's dividend payout ratio (DPR) is presently 49.35%.

Insider Activity at The Cigna Group

In other The Cigna Group news, CEO David Cordani sold 26,527 shares of the company's stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $308.12, for a total value of $8,173,499.24. Following the sale, the chief executive officer now owns 127,767 shares in the company, valued at approximately $39,367,568.04. The trade was a 17.19 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Noelle K. Eder sold 9,944 shares of the stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $320.00, for a total value of $3,182,080.00. Following the completion of the sale, the insider now directly owns 13,406 shares of the company's stock, valued at approximately $4,289,920. The trade was a 42.59 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 41,375 shares of company stock worth $12,866,600 in the last quarter. 0.60% of the stock is owned by insiders.

Institutional Trading of The Cigna Group

A number of hedge funds have recently added to or reduced their stakes in CI. Castle Rock Wealth Management LLC boosted its holdings in shares of The Cigna Group by 6.3% during the 4th quarter. Castle Rock Wealth Management LLC now owns 7,067 shares of the health services provider's stock valued at $2,066,000 after acquiring an additional 416 shares in the last quarter. Copley Financial Group Inc. raised its position in The Cigna Group by 7.8% in the fourth quarter. Copley Financial Group Inc. now owns 1,347 shares of the health services provider's stock valued at $372,000 after purchasing an additional 98 shares during the last quarter. Park Square Financial Group LLC acquired a new stake in shares of The Cigna Group during the fourth quarter valued at about $62,000. Total Wealth Planning & Management Inc. bought a new stake in shares of The Cigna Group during the fourth quarter worth about $402,000. Finally, Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of The Cigna Group in the fourth quarter valued at approximately $77,488,000. Institutional investors and hedge funds own 86.99% of the company's stock.

Wall Street Analysts Forecast Growth

CI has been the subject of several research analyst reports. Barclays reduced their target price on shares of The Cigna Group from $420.00 to $339.00 and set an "overweight" rating for the company in a report on Friday, January 31st. Stephens reduced their price target on The Cigna Group from $410.00 to $380.00 and set an "overweight" rating for the company in a research note on Friday, January 31st. Oppenheimer lowered their price objective on The Cigna Group from $400.00 to $375.00 and set an "outperform" rating on the stock in a research report on Friday, January 31st. Raymond James reissued a "strong-buy" rating and issued a $360.00 target price (down previously from $415.00) on shares of The Cigna Group in a research report on Friday, January 31st. Finally, Cantor Fitzgerald lowered their price target on shares of The Cigna Group from $400.00 to $350.00 and set an "overweight" rating on the stock in a research report on Friday, January 31st. Two equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat, The Cigna Group has an average rating of "Buy" and an average target price of $372.31.

About Representative Shreve

Jefferson Shreve (Republican Party) is a member of the U.S. House, representing Indiana's 6th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Shreve (Republican Party) is running for re-election to the U.S. House to represent Indiana's 6th Congressional District. He declared candidacy for the 2026 election. Email editor@ballotpedia.org to notify us of updates to this biography. Jefferson Shreve earned a bachelor's degree from Indiana University in 1989, a graduate degree from the University of London in 1998, and a graduate degree from Purdue University in 2003. Shreve's career experience includes working as a real estate executive. Shreve was elected 7th District Vice Chairman of the Indiana Republican State Committee on January 17, 2018, and was re-elected on March 6, 2021. In 2020, he was selected as a district-level delegate to the 2020 Republican National Convention.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.